• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Elizabeth L. Ciemins, PhD, MPH, MA

Latest:

Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.


Carl B. Abbott, PharmD

Latest:

Real-World Users of Triple Therapy for Asthma in the US

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.


Marco Meglio

Latest:

FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy

The new drug application (NDA) includes data from a global placebo-controlled, 72-week study as well as findings from the STRIDE registry, an ongoing, observational, real-world study of ataluren in routine care.


Frank J. Palella, MD

Latest:

Key Takeaways for the Management of HIV PrEP

A panel of experts share closing thoughts and advice for the management and uptake of HIV PrEP therapy.


Jeff McPheeters, BA

Latest:

Health Care Costs Associated With Unrecognized Progression to Late-Stage Kidney Disease

Unrecognized disease progression is associated with higher health care costs both for patients with end-stage kidney disease and late-stage (stages G4-G5) chronic kidney disease.


Aaron L. Schwartz, MD, PhD

Latest:

Trends in Low-Value Cancer Care During the COVID-19 Pandemic

Among adults with newly diagnosed cancer, rates of low-value cancer services persisted throughout the COVID-19 pandemic in areas ranging from peridiagnosis imaging to end-of-life care.


Lana Pine

Latest:

Clinical Disease Control in Psoriatic Arthritis Improves Quality of Life

Responders at week 104 demonstrated more significant changes from baseline and achieved normative values in PROs compared with non-responders.


Sophia Guzikowski, BSPH

Latest:

The Role of Race, Ethnicity, and Language in Care Transitions

Diverse patients experience disparities in care transitions. A survey of 224 patients showed differences by race, ethnicity, and language in technology access and in patient worries post discharge.


Huong Q. Nguyen, PhD, RN

Latest:

Telehealth Transitional Care and 30-Day Readmission During the COVID-19 Pandemic

This study found that the dramatic shift from face-to-face posthospital transitional care to telehealth did not affect 30-day readmission or mortality during the COVID-19 pandemic.


Brad Jordan, PhD

Latest:

What’s Next for Real-World Evidence in Oncology?

Recent steps by FDA to promote the use of real-world evidence are to be commended, but the future demands a broader vision that makes greater use of growing sources of health care information.


Samantha Randall, BA

Latest:

Beyond Average Spending: Distributional and Seasonal Commercial Insurance Trends, 2012-2021

Analysis of 2012-2021 commercial claims demonstrates that spending growth was concentrated among the highest spenders and there was increasing subsidy across enrollees through cost-sharing design.


Cecilia Ganduglia Cazaban, MD, DrPH

Latest:

Evaluation of a Collaborative Model Between Managed Care and Affordable Housing on Acute Care Costs

A collaborative service model between a managed care organization and an affordable housing provider reduced acute care use and costs.


Sujit S. Sansgiry, PhD, MS

Latest:

Economic Burden of Nonadherence to Standards of Diabetes Care

Using propensity score matching in a US nationally representative sample, authors found the effect of nonadherence to diabetes guidelines on health care expenditures of patients with diabetes.


Suhail Thahir, MS

Latest:

Quantifying the Insurance Value for Rare Diseases: Duchenne Muscular Dystrophy

The degree to which novel value elements such as insurance value impact estimated treatment value for rare, severe genetic diseases such as Duchenne muscular dystrophy is unclear.


Robert Green, PharmD

Latest:

Institutional Practices for Charitable Medication Access for Uninsured Patients

Analysis of a patient sample enrolled in charitable care at an academic medical center revealed that chronic medications were variably filled at a significant cost.


R. Sacha Bhatia, MD

Latest:

Agreement Among Measures Examining Low-Value Imaging for Low Back Pain

This study demonstrates the need for additional consensus surrounding how to translate guideline recommendations to administrative measures assessing imaging overuse for acute low back pain.


Shiva Salehian, MD, PhD, MPH

Latest:

Health Plan Switching and Satisfaction in a Medicaid MLTSS Program

Health plan dissatisfaction was higher among Medicaid managed long-term services and supports (MLTSS) beneficiaries who did not follow through with an intention to change health plans.


Kristina A. Monteiro, PhD

Latest:

Social Determinants of Health: Are Colonoscopies Always Fit for Duty?

Social determinants of health are associated with colonoscopy noncompletion in a Medicaid patient population at the Providence Community Health Centers.


JoAnne Collins, MPH

Latest:

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.


Elaine R. Gustetic, LCSW

Latest:

Impact of Advance Care Planning Consults on Advance Directives Completion

Implementing advance care planning consults can increase advance directive completion rates. The authors demonstrate the impact of consults on completed advance directives in the medical record.


Jason Fish, MD, MSHS

Latest:

Differences in Savings and Quality by Type of ACO Model

2016-2018 Next Generation Accountable Care Organization (ACO) and Medicare Shared Savings Program cost and quality data show similar performance, suggesting that increasing financial risk to health systems may not affect performance.


Erin O'Brien

Latest:

Study Explores Effects of Experimenter Sex on Ketamine Response

The underlying neural mechanisms identified may help clinicians better understand ketamine response in human patients.


Matthew F. Basilico, MD, PhD

Latest:

Discharge Prescribing and Subsequent Opioid Use After Traumatic Musculoskeletal Injury

The authors use surgical resident assignment as an instrumental variable for discharge opioid prescribing and estimate the impact of discharge opioid supply on subsequent use.




Jeffrey Vietri, PhD

Latest:

Financial Incentives Tied to Medicare Star Ratings: Impact on Influenza Vaccination Uptake in Medicare Beneficiaries

Influenza vaccine uptake improved among Medicare Advantage enrollees when influenza vaccination was introduced as a performance metric in Medicare star ratings and accompanying bonus payments.


Adrianne W. Casebeer, PhD

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Alexandra Gerlach

Latest:

Making Cancer Care Easier With Community Bispecific Antibody Programs

Allowing patients to stay in their homes to receive bispecific antibodies can make the whole cancer journey easier, explained Courtney VanHouzen, PharmD, of Cowell Family Cancer Center, Munson Healthcare.


Bram Fleuren, PhD, MSc

Latest:

Addressing Evolving Patient Concerns Around Telehealth in the COVID-19 Era

With a rapid shift to telehealth during the coronavirus disease 2019 (COVID-19) pandemic, clinicians, health care organizations, and policy makers must consider and address patients’ evolving needs, concerns, and expectations.


Martin S. Andersen, PhD

Latest:

Association of Opioid Utilization Management With Prescribing and Overdose

Opioid utilization management in Medicare was associated with mixed effects on opioid prescribing, and prior authorization was associated with a decreased likelihood of subsequent overdose.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.